Billionaire Texan Heir Is Helping Bring Back the Woolly Mammoth
A Texas oil heir’s quest to make Dallas a hub for biotech is showing signs of paying off,
2023-12-01 22:18
A Biotech Slump Is Emptying Labs and Threatening Research on New Drugs
Sangamo Therapeutics Inc.’s cost cuts didn’t hurt just the roughly 162 US workers who lost their jobs this
2023-11-23 02:47
Blackstone Is Lead Bidder in Signature Bank Property-Loan Sale
Blackstone Inc. is the frontrunner to win a roughly $17 billion portfolio of commercial-property loans from the Federal
2023-11-20 00:15
Cyber ‘Catastrophe Bonds’ Move Step Closer to Hitting Public Debt Markets
Cyber catastrophe bonds may be about to move out of the shadows of private deal-making and into the
2023-11-13 15:25
Moderna Raises Covid Shot Sales Guidance on Japan, US Pacts
Moderna Inc. raised its Covid-19 vaccine sales outlook for the year, finalizing contracts with Japan and several American
2023-08-03 22:27
China Drug-Price Negotiations Offers Glimpse Into Future for Companies in US
As drugmakers in the US steel for price negotiations ushered in by President Joe Biden’s Inflation Reduction Act,
2023-08-03 10:17
Merck Raises 2023 Sales Forecast as Cancer Drug Keytruda, Gardasil Vaccine Surge
Merck & Co.’s Keytruda and Gardasil soundly beat analysts’ estimates for quarterly sales, driving the company’s annual revenue
2023-08-01 19:25
Japan Unveils $6 Billion Deal to Buy Out Chip Linchpin JSR
Japan’s government unveiled a $6.3 billion deal to buy out and privatize JSR Corp., taking direct control of
2023-06-26 16:58
Chinese Premier Tells German CEOs to Take Lead on ‘De-risking’
Chinese Premier Li Qiang called for “de-risking” decisions to be taken by companies rather than governments during a
2023-06-20 11:59
Merck Sues US, Calling Move to Cut Drug Prices ‘Extortion’
Merck & Co. is suing the US over a law that will allow the government to negotiate prescription-drug
2023-06-07 01:46
Drugmakers Eye $23 Billion Biotech Argenx Ahead of Key Data
European biotech firm Argenx SE is scheduled to release key drug trial data this summer. Deal-hungry Big Pharma
2023-05-17 16:20